Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
37.38
-0.65 (-1.70%)
At close: Jun 6, 2025, 4:00 PM
37.30
-0.08 (-0.20%)
After-hours: Jun 6, 2025, 4:05 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Immunotherapies
310.20M
Log In
Log In
Log In
Log In
Upgrade
Immunotherapies Growth
24.37%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
226.90M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
25.72%
Log In
Log In
Log In
Log In
Upgrade
Europe
73.22M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
8.27%
Log In
Log In
Log In
Log In
Upgrade
International
10.08M
Log In
Log In
Log In
Log In
Upgrade
International Growth
665.81%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-
Log In
Log In
Log In
Log In
Upgrade